Jan E Brinchmann

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint Expanding autologous multipotent mesenchymal bone marrow stromal cells
    Jan E Brinchmann
    Cell Therapy, Institute of Immunology, Rikshospitalet Medical Centre, Oslo, Norway
    J Neurol Sci 265:127-30. 2008
  2. ncbi request reprint In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability
    Aboulghassem Shahdadfar
    Institute of Immunology, Rikshospitalet University Hospital, 0027 Oslo, Norway
    Stem Cells 23:1357-66. 2005
  3. doi request reprint Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum
    John Arne Dahl
    Department of Biochemistry, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, and Rikshospitalet Medical Centre, Oslo, Norway
    Int J Dev Biol 52:1033-42. 2008
  4. doi request reprint Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds
    Shivali Duggal
    Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway
    Tissue Eng Part A 15:1763-73. 2009
  5. doi request reprint Modulation of DNA glycosylase activities in mesenchymal stem cells
    Gunn A Hildrestrand
    Centre for Molecular Biology and Neuroscience and Institute of Medical Microbiology, Rikshospitalet University Hospital, Oslo, Norway
    Exp Cell Res 315:2558-67. 2009

Collaborators

  • Philippe Collas
  • Shivali Duggal
  • Aboulghassem Shahdadfar
  • Gunn A Hildrestrand
  • John Arne Dahl
  • Krisztina Szoke
  • Katrine B Frønsdal
  • Jan Egil Melvik
  • Luisa Luna
  • Magnar Bjørås
  • Douglas Millar
  • Neralie Coulston
  • John Melki
  • Katrine Frønsdal
  • Finn P Reinholt
  • Terje Haug

Detail Information

Publications5

  1. ncbi request reprint Expanding autologous multipotent mesenchymal bone marrow stromal cells
    Jan E Brinchmann
    Cell Therapy, Institute of Immunology, Rikshospitalet Medical Centre, Oslo, Norway
    J Neurol Sci 265:127-30. 2008
    ..To obtain the best cell culture conditions, a number of methodological decisions have to be made. Special considerations are necessary if the cells are to be used for the treatment of patients...
  2. ncbi request reprint In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability
    Aboulghassem Shahdadfar
    Institute of Immunology, Rikshospitalet University Hospital, 0027 Oslo, Norway
    Stem Cells 23:1357-66. 2005
    ..Thus, hMSCs may be expanded rapidly and with stable gene expression in AS in the absence of growth factors, whereas FBS induces a more differentiated and less stable transcriptional profile...
  3. doi request reprint Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum
    John Arne Dahl
    Department of Biochemistry, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, and Rikshospitalet Medical Centre, Oslo, Norway
    Int J Dev Biol 52:1033-42. 2008
    ....
  4. doi request reprint Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds
    Shivali Duggal
    Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway
    Tissue Eng Part A 15:1763-73. 2009
    ..As alginate may be entirely dissolved, leaving the cells as single cell suspensions for various analyses, this represents a useful model for the study of cells in 3D cultures...
  5. doi request reprint Modulation of DNA glycosylase activities in mesenchymal stem cells
    Gunn A Hildrestrand
    Centre for Molecular Biology and Neuroscience and Institute of Medical Microbiology, Rikshospitalet University Hospital, Oslo, Norway
    Exp Cell Res 315:2558-67. 2009
    ..The glycosylase activities remained stable through at least 12 passages, suggesting that DNA repair is proficient through the period required for in vitro expansion of AT-MSCs to clinically relevant numbers...